Published in Addiction on November 01, 2012
RCT Comparing Methadone and Buprenorphine in Pregnant Women | NCT00271219
The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month. Am J Psychiatry (2015) 1.45
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction (2012) 1.25
Developmental consequences of fetal exposure to drugs: what we know and what we still must learn. Neuropsychopharmacology (2014) 0.94
The use of central nervous system active drugs during pregnancy. Pharmaceuticals (Basel) (2013) 0.92
Placental HTR2A methylation is associated with infant neurobehavioral outcomes. Epigenetics (2013) 0.91
Epigenetic Regulation of Placental NR3C1: Mechanism Underlying Prenatal Programming of Infant Neurobehavior by Maternal Smoking? Child Dev (2016) 0.79
Depression-like effect of prenatal buprenorphine exposure in rats. PLoS One (2013) 0.77
Growth and developmental outcome of infants with in-utero exposure to methadone vs buprenorphine. J Perinatol (2015) 0.75
Neonatal abstinence syndrome: Neurobehavior at 6 weeks of age in infants with or without pharmacological treatment for withdrawal. Dev Psychobiol (2017) 0.75
Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med (2010) 3.84
The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics (2002) 3.07
Smoking during pregnancy and newborn neurobehavior. Pediatrics (2003) 2.93
Opioid dependence during pregnancy. Effects and management. Obstet Gynecol Clin North Am (1998) 2.33
Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend (2005) 2.26
Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction (2006) 2.04
Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution. Drug Alcohol Depend (2005) 1.90
Maternal smoking during pregnancy and newborn neurobehavior: effects at 10 to 27 days. J Pediatr (2008) 1.88
Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat (2008) 1.77
The opioid-exposed newborn: assessment and pharmacologic management. J Opioid Manag (2009) 1.70
Neonatal neurobehavior predicts medical and behavioral outcome. Pediatrics (2009) 1.67
Buprenorphine treatment of pregnant opioid--dependent women: maternal and neonatal outcomes. Drug Alcohol Depend (2001) 1.46
Treatment of opioid-dependent pregnant women with buprenorphine. Addiction (2000) 1.41
Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants. J Pediatr (2002) 1.26
Neurobehavioral effects of treatment for opiate withdrawal. Arch Dis Child Fetal Neonatal Ed (2005) 1.13
Maternal depression and neurobehavior in newborns prenatally exposed to methamphetamine. Neurotoxicol Teratol (2008) 1.07
Prenatal methadone exposure and neonatal neurobehavioral functioning. Pediatr Res (2009) 1.02
The role of relationship-based developmentally supportive newborn intensive care in strengthening outcome of preterm infants. Semin Perinatol (1997) 0.97
Infant neurobehavior following prenatal exposure to methadone or buprenorphine: results from the neonatal intensive care unit network neurobehavioral scale. Subst Use Misuse (2010) 0.96
Fetal neurobehavioral effects of exposure to methadone or buprenorphine. Neurotoxicol Teratol (2010) 0.94
Neonatal behavior after drug dependent pregnancy. Arch Dis Child (1989) 0.92
Fetal effects. Neurol Clin (1993) 0.89
State systems development in high-risk newborns in the neonatal intensive care unit: identification and management of sleep, alertness, and crying. J Perinat Neonatal Nurs (2007) 0.88
State organization in neonates: developmental inconsistency indicates risk for developmental dysfunction. Neuropediatrics (1981) 0.86
Facilitating infant adaptation: the nursery environment. Semin Neonatol (2002) 0.80
Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol (2015) 5.10
Amyloid ion channels: a common structural link for protein-misfolding disease. Proc Natl Acad Sci U S A (2005) 3.91
Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med (2010) 3.84
Smoking during pregnancy and newborn neurobehavior. Pediatrics (2003) 2.93
Disparities in diabetes care: impact of mental illness. Arch Intern Med (2005) 2.45
Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend (2005) 2.26
Influence of topology on bacterial social interaction. Proc Natl Acad Sci U S A (2003) 2.07
The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics (2006) 1.98
Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol Teratol (2007) 1.90
Maternal smoking during pregnancy and newborn neurobehavior: effects at 10 to 27 days. J Pediatr (2008) 1.88
Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat (2008) 1.77
The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. Pediatrics (2004) 1.61
Regional brain morphometry and impulsivity in adolescents following prenatal exposure to cocaine and tobacco. JAMA Pediatr (2013) 1.61
Placental 11-beta hydroxysteroid dehydrogenase methylation is associated with newborn growth and a measure of neurobehavioral outcome. PLoS One (2012) 1.58
Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy. Addiction (2005) 1.57
A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3. Hepatology (2008) 1.56
Impact of prenatal exposure to cocaine and tobacco on diffusion tensor imaging and sensation seeking in adolescents. J Pediatr (2011) 1.53
Low birth weight and preterm births: etiologic fraction attributable to prenatal drug exposure. J Perinatol (2005) 1.52
Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. Addiction (2008) 1.51
Calcium-dependent open/closed conformations and interfacial energy maps of reconstituted hemichannels. J Biol Chem (2004) 1.44
Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus? J Matern Fetal Neonatal Med (2012) 1.43
Longitudinal study of maternal report of sleep problems in children with prenatal exposure to cocaine and other drugs. Behav Sleep Med (2009) 1.42
Mortality among patients with acute myocardial infarction: the influences of patient-centered care and evidence-based medicine. Health Serv Res (2010) 1.41
Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend (2003) 1.36
Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis. World J Gastroenterol (2010) 1.34
Management of neonatal abstinence syndrome in neonates born to opioid maintained women. Drug Alcohol Depend (2006) 1.31
Biomechanical properties of native basement membranes. FEBS J (2007) 1.31
Assessment of infant cry: acoustic cry analysis and parental perception. Ment Retard Dev Disabil Res Rev (2005) 1.30
Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. Drug Alcohol Depend (2004) 1.26
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction (2012) 1.25
Normative neurobehavioral performance of healthy infants on the Neonatal Intensive Care Unit Network Neurobehavioral Scale. Pediatrics (2004) 1.24
Prenatal cocaine use and maternal depression: effects on infant neurobehavior. Neurotoxicol Teratol (2006) 1.22
Mood disorders affect drug treatment success of drug-dependent pregnant women. J Subst Abuse Treat (2006) 1.22
Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand. Neurotoxicol Teratol (2010) 1.22
Quantum mechanical/molecular mechanical investigation of the mechanism of C-H hydroxylation of camphor by cytochrome P450cam: theory supports a two-state rebound mechanism. J Am Chem Soc (2004) 1.22
Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study. J Pediatr (2010) 1.21
Racial/ethnic differences in diabetes care for older veterans: accounting for dual health system use changes conclusions. Med Care (2006) 1.20
The elusive oxidant species of cytochrome P450 enzymes: characterization by combined quantum mechanical/molecular mechanical (QM/MM) calculations. J Am Chem Soc (2002) 1.19
Nitric oxide-cGMP-protein kinase G pathway negatively regulates vascular transient receptor potential channel TRPC6. J Physiol (2008) 1.19
A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes. Subst Abuse (2013) 1.16
Patterns of methamphetamine use during pregnancy: results from the Infant Development, Environment, and Lifestyle (IDEAL) Study. Matern Child Health J (2009) 1.16
Response to Wouldes and Woodward: maternal methadone dose during pregnancy and infant clinical outcome. Neurotoxicol Teratol (2013) 1.15
Perinatal lead and mercury exposure in Austria. Sci Total Environ (2010) 1.15
Anxiety as a predictor of relapse in detoxified alcohol-dependent patients. Alcohol Alcohol (2002) 1.14
Functional MRI and response inhibition in children exposed to cocaine in utero. Preliminary findings. Dev Neurosci (2009) 1.14
Unintended pregnancy in opioid-abusing women. J Subst Abuse Treat (2010) 1.14
Maternal Opioid Treatment: Human Experimental Research (MOTHER)--approach, issues and lessons learned. Addiction (2012) 1.13
Study on acetate ion recognition and sensing in aqueous media using a novel and simple colorimetric sensor and its analytical application. Talanta (2007) 1.12
A decade of Bt cotton in Chinese fields: assessing the direct effects and indirect externalities of Bt cotton adoption in China. Sci China Life Sci (2010) 1.12
Sleep problems in children with prenatal substance exposure: the Maternal Lifestyle study. Arch Pediatr Adolesc Med (2010) 1.12
Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction (2003) 1.11
Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm. Biochim Biophys Acta (2007) 1.11
Iron deficiency anaemia can be improved after eradication of Helicobacter pylori. Postgrad Med J (2010) 1.11
Differences in tissue-remodeling potential of aortic and pulmonary heart valve interstitial cells. Tissue Eng (2007) 1.11
Cocaine use in Europe - a multi-centre study. Methodology and prevalence estimates. Eur Addict Res (2004) 1.10
Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data. Am J Addict (2013) 1.10
Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study. Ther Drug Monit (2009) 1.10
Parenting intervention for externalizing behavior problems in children born premature: an initial examination. J Dev Behav Pediatr (2010) 1.10
Predictors of motor development in children prenatally exposed to cocaine. Neurotoxicol Teratol (2004) 1.09
The combined effects of prenatal drug exposure and early adversity on neurobehavioral disinhibition in childhood and adolescence. Dev Psychopathol (2011) 1.09
A partner's drug-using status impacts women's drug treatment outcome. Drug Alcohol Depend (2003) 1.08
Maternal depression and neurobehavior in newborns prenatally exposed to methamphetamine. Neurotoxicol Teratol (2008) 1.07
Association between prenatal tobacco exposure and outcome of neonates born to opioid-maintained mothers. Implications for treatment. Eur Addict Res (2009) 1.07
The impact of managed care on drug-dependent pregnant and postpartum women and their children. Subst Use Misuse (2007) 1.07
alpha-Tocopherol intake and plasma concentration of Hispanic and non-Hispanic white elders is associated with dietary intake pattern. J Nutr (2006) 1.07
Demographic and psychosocial characteristics of mothers using methamphetamine during pregnancy: preliminary results of the infant development, environment, and lifestyle study (IDEAL). Am J Drug Alcohol Abuse (2007) 1.05
Placenta-imprinted gene expression association of infant neurobehavior. J Pediatr (2011) 1.05
A new method for stranded whole transcriptome RNA-seq. Methods (2013) 1.05
Impact of maternal substance use during pregnancy on childhood outcome. Semin Fetal Neonatal Med (2007) 1.04
Quality of life in patients receiving opioid maintenance therapy. A comparative study of slow-release morphine versus methadone treatment. Eur Addict Res (2008) 1.03
Patterning in placental 11-B hydroxysteroid dehydrogenase methylation according to prenatal socioeconomic adversity. PLoS One (2013) 1.03
Cocaine use in Europe - a multi-centre study: patterns of use in different groups. Eur Addict Res (2004) 1.03
Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine. J Addict Dis (2010) 1.03
The effect of parenting stress on child behavior problems in high-risk children with prenatal drug exposure. Child Psychiatry Hum Dev (2008) 1.03
Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age. Pediatrics (2012) 1.03
Substance abuse in patients with schizophrenia. Dialogues Clin Neurosci (2006) 1.02
DDIG-in: discriminating between disease-associated and neutral non-frameshifting micro-indels. Genome Biol (2013) 1.02
Global and gene-specific DNA methylation across multiple tissues in early infancy: implications for children's health research. FASEB J (2014) 1.02
Drug use and HIV risk outcomes in opioid-injecting men in the Republic of Georgia: behavioral treatment + naltrexone compared to usual care. Drug Alcohol Depend (2011) 1.02
Atypical cry acoustics in 6-month-old infants at risk for autism spectrum disorder. Autism Res (2012) 1.00
Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine. Neurotoxicol Teratol (2011) 1.00
COPI transport complexes bind to specific RNAs in neuronal cells. Hum Mol Genet (2012) 0.99
Fetal effects of psychoactive drugs. Clin Perinatol (2009) 0.99
Interactions between maternal characteristics and neonatal behavior in the prediction of parenting stress and perception of infant temperament. J Pediatr Psychol (2005) 0.99
Vagal tone as a resilience factor in children with prenatal cocaine exposure. Dev Psychopathol (2007) 0.98
Comparing homeless and domiciled pregnant substance dependent women on psychosocial characteristics and treatment outcomes. Drug Alcohol Depend (2003) 0.98
DEK overexpression in uterine cervical cancers. Pathol Int (2008) 0.98
The effects of prenatal methamphetamine exposure on childhood growth patterns from birth to 3 years of age. Am J Perinatol (2011) 0.98
Cigarette smoking knowledge, attitudes, and practices of patients and staff at a perinatal substance abuse treatment center. J Subst Abuse Treat (2010) 0.98
Violence and delinquency, early onset drug use, and psychopathology in drug-exposed youth at 11 years. Ann N Y Acad Sci (2006) 0.97
Double jeopardy--drug and sex risks among Russian women who inject drugs: initial feasibility and efficacy results of a small randomized controlled trial. Subst Abuse Treat Prev Policy (2012) 0.97
Importance of stability of early living arrangements on behavior outcomes of children with and without prenatal drug exposure. J Dev Behav Pediatr (2008) 0.97
Lessons learned from a randomized trial of fixed and escalating contingency management schedules in opioid-dependent pregnant women. Am J Drug Alcohol Abuse (2012) 0.97